Hoth Therapeutics logo
Hoth Therapeutics HOTH
$ 0.85 -5.45%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Hoth Therapeutics Balance Sheet 2011-2024 | HOTH

Annual Balance Sheet Hoth Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-9.24 M - - -2.63 M -1.69 M -283 K -1.23 M - - - - - -

Long Term Debt

26.3 K - - - - - - - - - - - -

Long Term Debt Current

28.8 K - - - - - - - - - - - -

Total Non Current Liabilities

- - - 285 K - - - - - - - - -

Total Current Liabilities

679 K 1.39 M 868 K 312 K 440 K 349 K - - - - - - -

Total Liabilities

705 K 1.64 M 1.1 M 597 K 440 K 349 K 49.5 K - - - - - -

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-52.9 M -45.1 M -33.7 M -19.4 M -12.2 M -4.51 M -2.02 M - - - - - -

Total Assets

9.52 M 6.76 M 11 M 5.24 M 2.84 M 504 K 1.23 M - - - - - -

Cash and Cash Equivalents

9.29 M 6.43 M 8.54 M 2.63 M 1.69 M 283 K - - - - - - -

Book Value

8.82 M 5.12 M 9.88 M 4.65 M 2.4 M 155 K 1.18 M - - - - - -

Total Shareholders Equity

8.82 M 5.12 M 9.88 M 4.65 M 2.4 M 155 K 1.18 M - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Hoth Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

2.71 K 11 K 18.9 K 26.3 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

2.71 K 11 K 18.9 K 26.3 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

813 K 692 K 659 K 705 K 1.58 M 1.97 M 1.6 M 1.64 M 1.28 M 1.03 M 1.06 M 1.1 M 1.84 M 1.45 M 1.04 M 597 K 597 K 597 K 597 K 440 K 440 K 440 K 440 K 349 K 349 K 349 K 349 K 49.5 K - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-58.7 M -56.6 M -55 M -52.9 M -51.2 M -49.2 M -47.3 M -45.1 M -41.6 M -39 M -36.3 M -33.7 M -30.2 M -27 M -23.7 M -19.4 M -19.4 M -19.4 M -19.4 M -12.2 M -12.2 M -12.2 M -12.2 M -4.51 M -4.51 M -4.51 M -4.51 M -2.02 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

8.31 M 10 M 8.49 M 9.52 M 12.1 M 11.9 M 13.5 M 6.76 M 9.89 M 12.3 M 8.95 M 11 M 15.2 M 18 M 21 M 5.24 M 5.24 M 5.24 M 5.24 M 2.84 M 2.84 M 2.84 M 2.84 M 504 K 504 K 504 K 504 K 1.23 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

8 M 9.65 M 7.56 M 9.29 M 11.8 M 11.5 M 13 M 6.43 M 8.94 M 11.3 M 6.38 M 8.54 M 12.4 M 15.9 M 19.3 M 2.63 M 2.63 M 2.63 M 2.63 M 1.69 M 1.69 M 1.69 M 1.69 M 283 K 283 K 283 K 283 K 1.23 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

7.49 M 9.34 M 7.83 M 8.82 M 10.5 M 9.95 M 11.9 M 5.12 M 8.61 M 11.2 M 7.88 M 9.88 M 13.3 M 16.6 M 19.9 M 4.65 M 4.65 M 4.65 M 4.65 M 2.4 M 2.4 M 2.4 M 2.4 M 155 K 155 K 155 K 155 K 1.18 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

7.49 M 9.34 M 7.83 M 8.82 M 10.5 M 9.95 M 11.9 M 5.12 M 8.61 M 11.2 M 7.88 M 9.88 M 13.3 M 16.6 M 19.9 M 4.65 M 4.65 M 4.65 M 4.65 M 2.4 M 2.4 M 2.4 M 2.4 M 155 K 155 K 155 K 155 K 1.18 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency